Vaccine At A Click! by Navin Chandra Mishra SignUp
Vaccine At A Click!
Navin Chandra Mishra Bookmark and Share


It appears that politicians and news media will make coronavirus vaccine available by magic out of a hat. The author intends to dwell upon this important subject.  There have been attempts to mislead the public by promising something which is not there as yet. We even come across people complaining worthlessness of Doctors and Scientists for not providing a medicine / vaccine.  Covid-19 pandemic has indeed thrown up challenges.

Let us remember that this Coronavirus is a new phenomenon having appeared recently in December 2019 in China. Development of vaccines is a long and tedious process which needs  to be explained to public at large. With advent of present information technology, people expect solutions to be available at a click!

News reports screaming that India would have a coronavirus vaccine in place by 15th August  have been in circulation. Director of ICMR (Indian Council of Medical Research) Mr Balram Bhargava reportedly ordered 12 hospitals to begin trial so that the vaccine would be ready by 15th August. Named Covaxin, this has been developed by Bharat Biotech, a Hyderabad based company in partnership with ICMR’s laboratory National Institute of Virology.

Dear reader, you must have guessed that the Director of ICMR probably wants to please the present Government so that this announcement can be made from the Red Fort on Independence Day. Or else, maybe, some astrologer has predicted the date of 15th August.

Future of entire human race may be compromised if processes are not followed for quick gains. There are inherent risks in rushing through such matters.

Historical Perspective

Development of vaccines is a long and complex process taking even 10 to 15 years.

Vaccines for small pox, rabies, plague, cholera and typhoid were developed by end of 19th century. The first smallpox vaccine came to India from England in the year 1802. Earlier India had its own version of inoculation for smallpox called variolation which was found to be unsafe and banned by the British. In China inoculation for smallpox existed as early as around 1000 AD.

Biologics Control Act was brought in the U.S.A in 1902 to regulate quality of drugs. There were two tetanus outbreaks – one from diphtheria antitoxin in St Louis and the other from contaminated smallpox vaccine in New Jersey. Investigations revealed that contaminated vaccine by the manufacturer was the culprit. This lead to the need for regulation.

There are several stages in the development of a vaccine which are dealt briefly below.

Initial   Stage

Scientists in laboratories identify antigens (which help produce antibodies) which help in prevention or treatment of a disease.  This research led identification may take upto 4 years.

Pre Clinical Stage

Generally animals are used to test the vaccine for triggering immunity from the disease. Rats and Monkeys are generally used in these experiments. Based upon detailed studies of these experiments decisions are made for the next stage of trials.

Trials at this stage generally take upto 2 years. Many vaccines fail at this stage and do not go to the next stage.

Vaccines successful at this stage go for clinical trials with humans in subsequent 3 stages.

Phase 1 Vaccine Trials

Target population for this phase is generally upto 100 persons. Assessment is made regarding safety of the vaccine and type of immunity response triggered in the man. Participants are infected with the pathogen (agent causing disease). Studies are carefully monitored in controlled condtions. Only when the results are promising one goes to the next stage.

Phase 2 Vaccine Trials

A larger group of several  hundreds  is taken at this stage. Those identified to as risk prone (likely to catch the disease are also included at this stage). These trials are randomized and controlled.

Aim of this phase is to study-

.Safety of the Vaccine

.Immunity Response

.Proposed Doses

.Frequency of Immunization

.Method of administering

Phase 3 Vaccine Trials

Vaccine found acceptable in stage 2 trials now go for further extensive trials. Group of persons (participants) now may go upto several thousands.

At this stage side effects of a vaccine often get noticed on account of the large population. At this stage vaccines are assessed for-

.Does it prevent disease

.Does it prevent disease with the pathogen

.Type of immune response / production of antibodies

After positive outcome of this stage the vaccine can go for commercial production and usage as per law of the respective country.

Here it is necessary to bear in mind that the participants have to be inclusive of male, female , females in different stages of pregnancy, different age groups, persons with identified medical conditions and of identified risk group.

It is indeed a challenge for any vaccine to succeed.

We should allow the scientists to work diligently on the development. Politicians and media should watch and report cautiously as lives are at stake.

Share This:
More by :  Navin Chandra Mishra
Views: 359      Comments: 3

Comments on this Blog

Comment It is true Mr Banerjee that some degree of compromise may be needed. For this standard procedures are in place. One hopes that it will be a informed and thought out decision. One becomes jittery when one sees some Head of States setting bad example (by not wearing masks or maintaining social distancing). These powerful politicians should not be allowed to handle the process of vaccine development.

07/28/2020 21:22 PM

Comment While more or less agreeing to the general contents of the blog,
it nevertheless could not be denied that some degree of compromise in the procedural part is the need of the hour to save precious human lives. What and how to compromise should be left to the experience and wisdom of the medical researchers and drug control authority.

Shambhu nath Banerjee
07/28/2020 09:02 AM

Comment Excellent piece Sir!

Certainly things are being compromised, given that herd-immunity is need of the hour.. Oxford-Astrazenca-Serum Institute(licensee in India-with huge production capacity) has taken lead.

Rakesh Ranjan Pandey
07/27/2020 20:53 PM

Name *
Email ID
 (will not be published)
Verification Code*
Can't read? Reload
Please fill the above code for verification.

1999-2020 All Rights Reserved
No part of this Internet site may be reproduced without prior written permission of the copyright holder